Global In-Vitro Colorectal Cancer Screening Tests Market to grow at over 5% CAGR from 2016 to 2023

1
Immuno-FOB ELISA Test of In-Vitro Colorectal
Cancer Screening Tests Market share shows growth
of 4 from 2016 to 2023 Global Market Insights
Inc.
Fuel Cell Market size worth 25.5bn by 2024
2
Key Insights from In-vitro Colorectal Cancer
Screening Tests Market

• Introduction of favorable government initiatives
  is poised to rise the industry demand over the
  coming years. Colorectal cancer (CRC) yearly
  affects over one million women and men and causes
  more than half a million deaths.
• In-Vitro Colorectal Cancer Screening Tests Market
  size will exceed USD 900 million by 2023
  according to a new research report by Global
  Market Insights, Inc.
• UK and Germany in-vitro colorectal cancer
  screening tests market exhibits high growth due
  to increasing prevalence of disease. Germany
  in-vitro colorectal cancer screening tests market
  share is likely to grow at significant rate by
  2023 with increasing government initiatives to
  improve cancer control with screening quality and
  healthcare funding.

3
Continued...

• Fecal occult blood (FOBT) testing is the most
  frequently used method. It is less expensive and
  has grownup existence in the healthcare industry
  in contrast to other tests. Methylated gene
  testing and transferrin assays are the new DNA
  screening and biomarker tests.
• Demand for CRC DNA screening tests may increase
  at the highest CAGR by 2023, due to increasing
  RD expenditure by major industry players in the
  advanced development. Immuno-FOB stool tests and
  transferrin assays has shown comparable accuracy
  owing to easy applicability and is forecast to
  observe rise in demand over the coming years.
• In 2016, nearly 60 - 70 of patients were
  suffering from CRC at mid or late stage when they
  were first-time diagnosed, leading to the high
  death rate. Recently, Cologuard (Exact Sciences)
  was approved by U.S. FDA and showed high CRC
  sensitivity (87) and adenomas (82).

4
Continued...

• North America, led by U.S. in-vitro colorectal
  cancer screening tests market was valued at over
  USD 250 million in 2015. High presence of
  geriatric population and increasing prevalence of
  colorectal cancer may drive regional growth.
• Asia Pacific, driven by China and Japan, will be
  the fastest growing in-vitro colorectal cancer
  screening tests market, on account of increasing
  number of geriatric population and unhealthy
  lifestyles leading to cancer. Brazil and Mexico
  should grow at approximately similar rate with
  increasing healthcare expenditure.
• Global in-vitro colorectal cancer screening tests
  market is marked by strategic associations,
  mergers and acquisitions, and partnerships to
  expand product range. Major industry players are
  Alere, Abbott, Eiken Chemical, Siemens Healthcare
  and Beckman Coulter. Strict government policies
  challenge new players from entering the industry.

5
Germany In-Vitro Colorectal Cancer Screening
Tests Market Size, By Type, 2012-2023 (USD
Million)

6

Browse Full Market Research Report On In-vitro
Colorectal Cancer Screening Tests Market _at_
http//bit.ly/2oodw2i Request for a Sample
of this Research Report _at_ https//www.gminsights.c
om/request-sample/detail/451 https//www.gminsigh
ts.com/request-sample/detail/49
7
Stay In Touch Website www.gminsights.com Soci
al Media